ivabradine has been researched along with Nerve Pain in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Baba, H; Ohashi, M; Ohashi, N; Uta, D | 1 |
Fuseya, S; Ishida, K; Ishida, T; Ito, M; Kawamata, M; Sakamoto, A; Tanaka, S | 1 |
Fuseya, S; Ishida, K; Kashihara, T; Kawagishi, H; Kawamata, M; Kiyosawa, K; Nakada, T; Tanaka, S; Yamada, M; Zhang, H | 1 |
Armstrong, G; Bond, S; Lee, MC; McNaughton, P; Menon, D; Scholtes, I; Wheeler, D | 1 |
Bukhanova, N; Chen, Y; Kumar, N; Noh, S; Smith, PA; Stemkowsi, PL | 1 |
Emery, EC; McNaughton, PA; Mooney, ER; Tsantoulas, C; Young, GT | 1 |
2 trial(s) available for ivabradine and Nerve Pain
Article | Year |
---|---|
A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers.
Topics: Adult; Analgesics; Calcium Channel Blockers; Capsaicin; Cross-Over Studies; Female; Healthy Volunteers; Humans; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Neuralgia; Nucleotides, Cyclic | 2022 |
A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.
Topics: Analgesics; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Hyperalgesia; Ivabradine; Neuralgia | 2019 |
4 other study(ies) available for ivabradine and Nerve Pain
Article | Year |
---|---|
Analgesic effect of ivabradine against inflammatory pain mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels expressed on primary afferent terminals in the spinal dorsal horn.
Topics: Analgesics; Animals; Cations; Cyclic Nucleotide-Gated Cation Channels; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nerve Fibers, Unmyelinated; Neuralgia; Rats; Spinal Cord Dorsal Horn | 2022 |
Prostanoid EP4 Receptor-Mediated Augmentation of
Topics: Animals; Dose-Response Relationship, Drug; Ganglia, Spinal; Injections, Spinal; Ivabradine; Male; Membrane Potentials; Neuralgia; Neurons; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides | 2019 |
The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain.
Topics: Analgesics; Animals; Arterial Pressure; Benzazepines; Disease Models, Animal; Female; Heart Rate; Hyperalgesia; Ivabradine; Male; Neuralgia; Pain Measurement; Pain Threshold; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley | 2014 |
Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels.
Topics: Animals; Benzazepines; Cells, Cultured; Female; Ganglia, Spinal; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Inflammation; Ivabradine; Male; Membrane Potentials; Mice; Neuralgia; Neurons; Patch-Clamp Techniques | 2014 |